Laboratory of Immunobiology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, University of Leuven, Leuven, Belgium.
Laboratory of Immunobiology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, University of Leuven, Leuven, Belgium; Laboratory of Molecular Immunology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, University of Leuven, Leuven, Belgium.
Trends Immunol. 2020 May;41(5):367-378. doi: 10.1016/j.it.2020.03.004. Epub 2020 Apr 13.
Autoimmune diseases are defined as pathologies of adaptive immunity by the presence of autoantibodies or MHC-restricted autoantigen-reactive T cells. Because autoreactivity is a normal process based on mechanisms producing repertoires of antibodies and T cell receptors, crucial questions about disease mechanisms and key steps for interference have been outstanding. We defined 25 years ago the 'remnant epitopes generate autoimmunity' (REGA)-model in which extracellular proteases from innate immune cells generate autoantigens. Here, we refine the REGA-model, tested in diseases ranging from organ-specific autoimmune diseases to systemic lupus erythematosus. It now constitutes a paradigm in which remnant epitopes generate, maintain, and regulate autoimmunity; are dependent on genetic and epigenetic influences; are produced in a disease phase-specific manner; and have therapeutic implications when targeted.
自身免疫性疾病被定义为适应性免疫的病理学,其特征是存在自身抗体或 MHC 受限的自身抗原反应性 T 细胞。由于自身反应性是一种基于产生抗体和 T 细胞受体库的正常过程,因此关于疾病机制和关键干预步骤的关键问题一直悬而未决。我们在 25 年前定义了“残留表位引发自身免疫”(REGA)模型,其中先天免疫细胞的细胞外蛋白酶产生自身抗原。在这里,我们对该模型进行了细化,该模型已在从器官特异性自身免疫性疾病到系统性红斑狼疮等疾病中进行了测试。现在,它构成了一个范例,其中残留表位产生、维持和调节自身免疫;受遗传和表观遗传影响;以疾病阶段特异性的方式产生;并且在靶向时具有治疗意义。